This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...